Trump is threatening U.S. pharma with tariffs of 100% to push them to bring manufacturing home, but it may not be so easy to dislodge companies from places like the Irish village of Ringaskiddy

Core Viewpoint - The president plans to impose 100% tariffs on companies that do not manufacture in America [1] Group 1 - The proposed tariffs aim to incentivize domestic manufacturing [1] - Companies that choose to manufacture abroad will face significant financial penalties [1]